BIOSCIENCE HEALTH INNOVATIONS INC. Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized
BIOSCIENCE HEALTH INNOVATIONS INC. (BHIC) reported Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized of $755.02 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized · last filed 2025-03-13
- BIOSCIENCE HEALTH INNOVATIONS INC. business combination, separately recognized transactions, expenses and losses recognized for the quarter ending 2023-12-31 was $274.89K.
- BIOSCIENCE HEALTH INNOVATIONS INC. business combination, separately recognized transactions, expenses and losses recognized for the quarter ending 2023-09-30 was $217.49K.
- BIOSCIENCE HEALTH INNOVATIONS INC. business combination, separately recognized transactions, expenses and losses recognized for the quarter ending 2023-06-30 was $257.35K.
- BIOSCIENCE HEALTH INNOVATIONS INC. business combination, separately recognized transactions, expenses and losses recognized for the quarter ending 2023-03-31 was $5.29K.
- BIOSCIENCE HEALTH INNOVATIONS INC. business combination, separately recognized transactions, expenses and losses recognized for fiscal 2023 was $755.02K.
| Period end | Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized 3 month | Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized 6 month | Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized 9 month | Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized 12 month |
|---|---|---|---|---|
| 2023-12-31 | $274.89K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $492.37K derived: sum of 2 quarters · filed 2025-03-13 | $749.72K derived: sum of 3 quarters · filed 2025-03-13 | $755.02K 10-K · filed 2025-03-13 |
| 2023-09-30 | $217.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | $474.83K derived: sum of 2 quarters · filed 2024-10-28 | $480.13K 10-Q · filed 2024-10-28 | |
| 2023-06-30 | $257.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $262.64K 10-Q · filed 2024-07-30 | ||
| 2023-03-31 | $5.29K 10-Q · filed 2024-05-03 |